We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
+11.9%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+498%
AUM
$1.41B
AUM Growth
+$125M
Cap. Flow
-$6.29M
Cap. Flow %
-0.45%
Top 10 Hldgs %
35.33%
Holding
276
New
13
Increased
51
Reduced
96
Closed
8

Top Buys

Rank Stock Value
1
CLF icon
Cleveland-Cliffs
CLF
+$3.71M
2
XOM icon
ExxonMobil
XOM
+$2.57M
3
PANW icon
Palo Alto Networks
PANW
+$1.41M
4
NVO
Novo Nordisk
NVO
+$1.2M
5
URI icon
United Rentals
URI
+$909K

Top Sells

Rank Stock Value
1
XLRN
Acceleron Pharma
XLRN
+$3.95M
2
VZ icon
Verizon
VZ
+$2.07M
3
NEE icon
NextEra Energy
NEE
+$1.38M
4
INTC icon
Intel
INTC
+$1.28M
5
IBM icon
IBM
IBM
+$1.12M

Sector Composition

Rank Sector Weight
1 Technology 23.1%
2 Healthcare 19.24%
3 Financials 13.15%
4 Industrials 11.27%
5 Communication Services 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTG icon
176
Reaves Utility Income Fund
UTG
$3.61B
$471K 0.03%
13,418
– –
OKE icon
177
Oneok
OKE
$54.5B
$470K 0.03%
8,000
– –
MPC icon
178
Marathon Petroleum
MPC
$83.7B
$465K 0.03%
7,264
– –
RNR icon
179
RenaissanceRe
RNR
$13.4B
$457K 0.03%
2,700
– –
AON icon
180
Aon
AON
$76B
$451K 0.03%
1,500
– –
HSIC icon
181
Henry Schein
HSIC
$9.82B
$449K 0.03%
5,790
-250
-4% -$19.1K
ZBH icon
182
Zimmer Biomet
ZBH
$18.4B
$445K 0.03%
3,605
– –
TDG icon
183
TransDigm Group
TDG
$67.7B
$442K 0.03%
695
– –
FLS icon
184
Flowserve
FLS
$10.2B
$429K 0.03%
14,005
– –
OUT icon
185
Outfront Media
OUT
$5.5B
$402K 0.03%
15,240
– –
STT icon
186
State Street
STT
$50.7B
$386K 0.03%
4,150
– –
HPE icon
187
Hewlett Packard
HPE
$70.5B
$379K 0.03%
24,050
– –
SBUX icon
188
Starbucks
SBUX
$120B
$368K 0.03%
3,147
-825
-21% -$93K
BLK icon
189
Blackrock
BLK
$176B
$366K 0.03%
400
– –
AMGN icon
190
Amgen
AMGN
$222B
$344K 0.02%
1,530
-175
-10% -$36.9K
GIS icon
191
General Mills
GIS
$19.7B
$331K 0.02%
4,907
– –
LLY icon
192
Eli Lilly
LLY
$1.06T
$331K 0.02%
1,200
– –
LHX icon
193
L3Harris
LHX
$53.4B
$329K 0.02%
1,542
– –
XLF icon
194
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
$329K 0.02%
8,430
– –
L icon
195
Loews
L
$23.6B
$327K 0.02%
5,670
– –
HES
196
DELISTED
Hess
HES
$309K 0.02%
4,175
-100
-2% -$8.11K
ACGL icon
197
Arch Capital
ACGL
$33.6B
$308K 0.02%
6,930
– –
XYZ
198
Block Inc
XYZ
$47.5B
$308K 0.02%
1,910
-550
-22% -$119K
GM icon
199
General Motors
GM
$76.8B
$299K 0.02%
5,100
– –
ET icon
200
Energy Transfer Partners
ET
$69.3B
$288K 0.02%
34,972
-768
-2% -$6.98K
6 7
8
9 10

Similar funds

BGCP
Bristol Gate Capital Partners Toronto, Ontario, Canada $1.55B AUM 12.75% 1-Year Est. Return
MSA
MUFG Securities Americas New York $1.55B AUM 28.4% 1-Year Est. Return
CET
Clean Energy Transition London, United Kingdom $1.54B AUM 34.41% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
CCM
Cinctive Capital Management New York $1.53B AUM 48.83% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
MCP
Meridiem Capital Partners Dallas, Texas $1.53B AUM 17.03% 1-Year Est. Return
SG
Sienna Gestion Paris, France $1.53B AUM 27.73% 1-Year Est. Return

Neville Rodie & Shaw's Q4 2021 Portfolio in Review

As of Q4 2021, Neville Rodie & Shaw held 276 positions worth $1.41B, up 9.7% from $1.29B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Neville Rodie & Shaw's Q4 2021 filing shows 13 new, 51 increased, 96 reduced and 8 closed positions. Its largest new stake was Cleveland-Cliffs: 172,300 shares worth $3.75M. The largest sale was Acceleron Pharma, an estimated $3.95M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • Neville Rodie & Shaw's largest Q4 2021 buy was Cleveland-Cliffs: 172,300 shares worth $3.75M.
  • Neville Rodie & Shaw added most to ExxonMobil in Q4 2021, an estimated $2.57M increase.
  • Neville Rodie & Shaw's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.07M.
  • Neville Rodie & Shaw fully exited Acceleron Pharma in Q4 2021, selling an estimated $3.95M.
  • Neville Rodie & Shaw's ten largest holdings make up 35% of its $1.41B portfolio in Q4 2021.
  • Neville Rodie & Shaw opened 13 new positions and closed 8 in Q4 2021.
  • Neville Rodie & Shaw's portfolio value rose 9.7% quarter-over-quarter to $1.41B.

Based on Neville Rodie & Shaw's 13F filing for Q4 2021, filed 5 Jan 2022.